These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27644563)

  • 1. Efficacy of proton pump inhibitor in combination with rikkunshito in patients complaining of globus pharyngeus.
    Nakano S; Iwasaki H; Kondo E; Miyazaki K; Shizuku H; Kamimura S; Fukuda J; Kanamura R; Takeda N
    J Med Invest; 2016; 63(3-4):227-9. PubMed ID: 27644563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rikkunshito improves globus sensation in patients with proton-pump inhibitor-refractory laryngopharyngeal reflux.
    Tokashiki R; Okamoto I; Funato N; Suzuki M
    World J Gastroenterol; 2013 Aug; 19(31):5118-24. PubMed ID: 23964146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.
    Lin RJ; Sridharan S; Smith LJ; Young VN; Rosen CA
    Laryngoscope; 2018 Jan; 128(1):133-137. PubMed ID: 28730666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflux finding score and reflux symptom index as potential predictors for proton pump inhibitor response in globus pharyngeus patients: A prospective study.
    Boom L; Edens M; Rinia B
    Auris Nasus Larynx; 2020 Aug; 47(4):609-615. PubMed ID: 32113831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures.
    Carroll TL; Fedore LW; Aldahlawi MM
    Laryngoscope; 2012 Nov; 122(11):2473-81. PubMed ID: 22965767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan.
    Tominaga K; Iwakiri R; Fujimoto K; Fujiwara Y; Tanaka M; Shimoyama Y; Umegaki E; Higuchi K; Kusano M; Arakawa T;
    J Gastroenterol; 2012 Mar; 47(3):284-92. PubMed ID: 22081052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
    Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study.
    Yoon YH; Park KW; Lee SH; Park HS; Chang JW; Koo BS
    Clin Otolaryngol; 2019 Jul; 44(4):612-618. PubMed ID: 31002475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of super high dose proton pump inhibitor administration in refractory laryngopharyngeal reflux: a pilot study.
    Portnoy JE; Gregory ND; Cerulli CE; Hawkshaw MJ; Lurie D; Katz PO; Sataloff RT
    J Voice; 2014 May; 28(3):369-77. PubMed ID: 24495427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of anti-reflux surgery on refractory laryngopharyngeal reflux disease in professional voice users: a pilot study.
    Weber B; Portnoy JE; Castellanos A; Hawkshaw MJ; Lurie D; Katz PO; Sataloff RT
    J Voice; 2014 Jul; 28(4):492-500. PubMed ID: 24629640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of proton pump inhibitors in patients with laryngopharyngeal reflux disease.
    Chiba T; Kudara N; Abiko Y; Endo M; Suzuki K; Sugai T; Ishijima K; Fukuda K; Yamazaki K; Sato H
    Hepatogastroenterology; 2011; 58(110-111):1580-2. PubMed ID: 21940324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Proton Pump Inhibitor Therapy for Laryngopharyngeal Reflux on Posttreatment Symptoms and Hypopharyngeal pH.
    Waxman J; Yalamanchali S; Valle ES; Pott T; Friedman M
    Otolaryngol Head Neck Surg; 2014 Jun; 150(6):1010-7. PubMed ID: 24647643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy.
    Tsutsui H; Manabe N; Uno M; Imamura H; Kamada T; Kusunoki H; Shiotani A; Hata J; Harada T; Haruma K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):893-9. PubMed ID: 22594305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial.
    Shen H; Han Y; Wu D; Hu L; Ma Y; Wu F; Tao Y; Liu Y
    Trials; 2022 Apr; 23(1):272. PubMed ID: 35395946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Pump Inhibitor Ameliorates Taste Disturbance among Patients with Laryngopharyngeal Reflux: A Randomized Controlled Study.
    Suzuki M; Yokota M; Matsumoto T; Nakayama M; Takemura M; Kanemitsu Y; Niimi A; Nakamura Y; Murakami S
    Tohoku J Exp Med; 2019 Jan; 247(1):19-25. PubMed ID: 30643081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the quality of life of patients with laryngopharyngeal reflux after treatment.
    Lee JS; Lee YC; Kim SW; Kwon KH; Eun YG
    J Voice; 2014 Jul; 28(4):487-91. PubMed ID: 24598356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitor Therapy for the Treatment of Laryngopharyngeal Reflux: A Meta-Analysis of Randomized Controlled Trials.
    Guo H; Ma H; Wang J
    J Clin Gastroenterol; 2016 Apr; 50(4):295-300. PubMed ID: 25906028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial.
    Lam PK; Ng ML; Cheung TK; Wong BY; Tan VP; Fong DY; Wei WI; Wong BC
    Clin Gastroenterol Hepatol; 2010 Sep; 8(9):770-6. PubMed ID: 20303417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Inhaled N-Acetylcysteine for Laryngopharyngeal Reflux Disease: A Randomized Controlled Trial.
    Jo YS; Choi IS; So YK
    J Voice; 2021 Jul; 35(4):618-624. PubMed ID: 31848062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease.
    Semmanaselvan K; Mukaddam QI; Naik M
    J Assoc Physicians India; 2015 Jul; 63(7):27-32. PubMed ID: 26731824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.